Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Vaginal Sildenafil for Primary Dysmenorrhea: An Open-Label Mechanistic Study

NCT07508358 is registered in ClinicalTrials.gov with Kevin Hellman as lead sponsor.

NCT NCT07508358
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07508358 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Vaginal Sildenafil for Primary Dysmenorrhea: An Open-Label Mechanistic Study
Lead sponsor
Kevin Hellman
Phase
Phase 1
Overall status
Not yet recruiting
Start date
October 1, 2026
Completion date
July 31, 2027
Enrollment
10 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dysmenorrhea, endometriosis, menstrual pain, uterine fibroid